|
1
|
American Cancer Society, . Cancer Facts
& Figures 2015American Cancer Society; Atlanta, GA: 2015
|
|
2
|
Baetke SC, Adriaens ME, Seigneuric R,
Evelo CT and Eijssen LM: Molecular pathways involved in prostate
carcinogenesis: Insights from public microarray datasets. PLoS One.
7:e498312012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Center MM, Jemal A, Lortet-Tieulent J,
Ward E, Ferlay J, Brawley O and Bray F: International variation in
prostate cancer incidence and mortality rates. Eur Urol.
61:1079–1092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kornmann B: Quality control in
mitochondria: Use it, break it, fix it, trash it. F1000Prime Rep.
6:152014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
van der Bliek AM, Sedensky MM and Morgan
PG: Cell biology of the mitochondrion. Genetics. 207:843–871. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parr RL, Mills J, Harbottle A, Creed JM,
Crewdson G, Reguly B and Guimont FS: Mitochondria, prostate cancer,
and biopsy sampling error. Discov Med. 15:213–220. 2013.PubMed/NCBI
|
|
7
|
Boland ML, Chourasia AH and Macleod KF:
Mitochondrial dysfunction in cancer. Front Oncol. 3:2922013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Costello LC and Franklin RB: The clinical
relevance of the metabolism of prostate cancer; zinc and tumor
suppression: Connecting the dots. Mol Cancer. 5:172006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Costello LC, Guan Z, Kukoyi B, Feng P and
Franklin RB: Terminal oxidation and the effects of zinc in prostate
versus liver mitochondria. Mitochondrion. 4:331–338. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Costello LC and Franklin RB: The
intermediary metabolism of the prostate: A key to understanding the
pathogenesis and progression of prostate malignancy. Oncology.
59:269–282. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vayalil PK and Landar A: Mitochondrial
oncobioenergetic index: A potential biomarker to predict
progression from indolent to aggressive prostate cancer.
Oncotarget. 6:43065–43080. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Panov A and Orynbayeva Z: Bioenergetic and
antiapoptotic properties of mitochondria from cultured human
prostate cancer cell lines PC-3, DU145 and LNCaP. PLoS One.
8:e720782013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Andersen KF, Divilov V, Sevak K,
Koziorowski J, Lewis JS and Pillarsetty N: Influence of free fatty
acids on glucose uptake in prostate cancer cells. Nucl Med Biol.
41:254–258. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hofer C, Laubenbacher C, Block T, Breul J,
Hartung R and Schwaiger M: Fluorine-18-fluorodeoxyglucose positron
emission tomography is useless for the detection of local
recurrence after radical prostatectomy. Eur Urol. 36:31–35. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu Y, Zuckier LS and Ghesani NV: Dominant
uptake of fatty acid over glucose by prostate cells: A potential
new diagnostic and therapeutic approach. Anticancer Res.
30:369–374. 2010.PubMed/NCBI
|
|
16
|
Diers AR, Vayalil PK, Oliva CR, Griguer
CE, Darley-Usmar V, Hurst DR, Welch DR and Landar A: Mitochondrial
bioenergetics of metastatic breast cancer cells in response to
dynamic changes in oxygen tension: Effects of HIF-1α. PLoS One.
8:e683482013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kramer PA, Chacko BK, Ravi S, Johnson MS,
Mitchell T, Barnes S, Arabshahi A, Dell'Italia LJ, George DJ,
Steele C, et al: Hemoglobin-associated oxidative stress in the
pericardial compartment of postoperative cardiac surgery patients.
Lab Invest. 95:132–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Franklin RB, Zou J, Yu Z and Costello LC:
EAAC1 is expressed in rat and human prostate epithelial cells;
functions as a high-affinity L-aspartate transporter; and is
regulated by prolactin and testosterone. BMC Biochem. 7:102006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mayers JR and Vander Heiden MG: Nature and
nurture: What determines tumor metabolic phenotypes? Cancer Res.
77:3131–3134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Parr RL, Dakubo GD, Thayer RE, McKenney K
and Birch-Machin MA: Mitochondrial DNA as a potential tool for
early cancer detection. Hum Genomics. 2:252–257. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vayalil PK, Oh JY, Zhou F, Diers AR, Smith
MR, Golzarian H, Oliver PG, Smith RA, Murphy MP, Velu SE and Landar
A: A novel class of mitochondria-targeted soft electrophiles
modifies mitochondrial proteins and inhibits mitochondrial
metabolism in breast cancer cells through redox mechanisms. PLoS
One. 10:e01204602015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smith MR, Vayalil PK, Zhou F, Benavides
GA, Beggs RR, Golzarian H, Nijampatnam B, Oliver PG, Smith RA,
Murphy MP, et al: Mitochondrial thiol modification by a targeted
electrophile inhibits metabolism in breast adenocarcinoma cells by
inhibiting enzyme activity and protein levels. Redox Biol.
8:136–148. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu M, Neilson A, Swift AL, Moran R,
Tamagnine J, Parslow D, Armistead S, Lemire K, Orrell J, Teich J,
et al: Multiparameter metabolic analysis reveals a close link
between attenuated mitochondrial bioenergetic function and enhanced
glycolysis dependency in human tumor cells. Am J Physiol Cell
Physiol. 292:C125–C136. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schöpf B, Schäfer G, Weber A, Talasz H,
Eder IE, Klocker H and Gnaiger E: Oxidative phosphorylation and
mitochondrial function differ between human prostate tissue and
cultured cells. FEBS J. 283:2181–2196. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chacko BK, Kramer PA, Ravi S, Benavides
GA, Mitchell T, Dranka BP, Ferrick D, Singal AK, Ballinger SW,
Bailey SM, et al: The bioenergetic health index: A new concept in
mitochondrial translational research. Clin Sci (Lond). 127:367–373.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brand MD and Nicholls DG: Assessing
mitochondrial dysfunction in cells. Biochem J. 435:297–312. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jastroch M, Divakaruni AS, Mookerjee S,
Treberg JR and Brand MD: Mitochondrial proton and electron leaks.
Essays Biochem. 47:53–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hill BG, Benavides GA, Lancaster JR Jr,
Ballinger S, Dell'Italia L, Jianhua Z and Darley-Usmar VM:
Integration of cellular bioenergetics with mitochondrial quality
control and autophagy. Biol Chem. 393:1485–1512. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dranka BP, Hill BG and Darley-Usmar VM:
Mitochondrial reserve capacity in endothelial cells: The impact of
nitric oxide and reactive oxygen species. Free Radic Biol Med.
48:905–914. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hill BG, Dranka BP, Zou L, Chatham JC and
Darley-Usmar VM: Importance of the bioenergetic reserve capacity in
response to cardiomyocyte stress induced by 4-hydroxynonenal.
Biochem J. 424:99–107. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nicolson GL: Mitochondrial dysfunction and
chronic disease: Treatment with natural supplements. Integr Med
(Encinitas). 13:35–43. 2014.PubMed/NCBI
|
|
32
|
Fiaschi T, Marini A, Giannoni E, Taddei
ML, Gandellini P, De Donatis A, Lanciotti M, Serni S, Cirri P and
Chiarugi P: Reciprocal metabolic reprogramming through lactate
shuttle coordinately influences tumor-stroma interplay. Cancer Res.
72:5130–5140. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shtivelman E, Beer TM and Evans CP:
Molecular pathways and targets in prostate cancer. Oncotarget.
5:7217–7259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li C, Li Y, He L, Agarwal AR, Zeng N,
Cadenas E and Stiles B: PI3K/AKT signaling regulates bioenergetics
in immortalized hepatocytes. Free Radic Biol Med. 60:29–40. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lightowlers RN, Chinnery PF, Turnbull DM
and Howell N: Mammalian mitochondrial genetics: Heredity,
heteroplasmy and disease. Trends Genet. 13:450–455. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wallace DC and Chalkia D: Mitochondrial
DNA genetics and the heteroplasmy conundrum in evolution and
disease. Cold Spring Harb Perspect Biol. 5:a0212202013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jerónimo C, Nomoto S, Caballero OL, Usadel
H, Henrique R, Varzim G, Oliveira J, Lopes C, Fliss MS and
Sidransky D: Mitochondrial mutations in early stage prostate cancer
and bodily fluids. Oncogene. 20:5195–5198. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jessie BC, Sun CQ, Irons HR, Marshall FF,
Wallace DC and Petros JA: Accumulation of mitochondrial DNA
deletions in the malignant prostate of patients of different ages.
Exp Gerontol. 37:169–174. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen JZ, Gokden N, Greene GF, Mukunyadzi P
and Kadlubar FF: Extensive somatic mitochondrial mutations in
primary prostate cancer using laser capture microdissection. Cancer
Res. 62:6470–6474. 2002.PubMed/NCBI
|
|
40
|
Chen JZ, Gokden N, Greene GF, Green B and
Kadlubar FF: Simultaneous generation of multiple mitochondrial DNA
mutations in human prostate tumors suggests mitochondrial
hyper-mutagenesis. Carcinogenesis. 24:1481–1487. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen JZ and Kadlubar FF: Mitochondrial
mutagenesis and oxidative stress in human prostate cancer. J
Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 22:1–12.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Petros JA, Baumann AK, Ruiz-Pesini E, Amin
MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, et
al: mtDNA mutations increase tumorigenicity in prostate cancer.
Proc Natl Acad Sci USA. 102:719–724. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Dakubo GD, Parr RL, Costello LC, Franklin
RB and Thayer RE: Altered metabolism and mitochondrial genome in
prostate cancer. J Clin Pathol. 59:10–16. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gómez-Zaera M, Abril J, González L, Aguiló
F, Condom E, Nadal M and Nunes V: Identification of somatic and
germline mitochondrial DNA sequence variants in prostate cancer
patients. Mutat Res. 595:42–51. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Higuchi M, Kudo T, Suzuki S, Evans TT,
Sasaki R, Wada Y, Shirakawa T, Sawyer JR and Gotoh A: Mitochondrial
DNA determines androgen dependence in prostate cancer cell lines.
Oncogene. 25:1437–1445. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Parr RL, Dakubo GD, Crandall KA, Maki J,
Reguly B, Aguirre A, Wittock R, Robinson K, Alexander JS,
Birch-Machin MA, et al: Somatic mitochondrial DNA mutations in
prostate cancer and normal appearing adjacent glands in comparison
to age-matched prostate samples without malignant histology. J Mol
Diagn. 8:312–319. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Khandrika L, Kumar B, Koul S, Maroni P and
Koul HK: Oxidative stress in prostate cancer. Cancer Lett.
282:125–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kloss-Brandstätter A, Schäfer G, Erhart G,
Hüttenhofer A, Coassin S, Seifarth C, Summerer M, Bektic J, Klocker
H and Kronenberg F: Somatic mutations throughout the entire
mitochondrial genome are associated with elevated PSA levels in
prostate cancer patients. Am J Hum Genet. 87:802–812. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ashtiani ZO, Heidari M, Hasheminasab SM,
Ayati M and Rakhshani N: Mitochondrial D-Loop polymorphism and
microsatellite instability in prostate cancer and benign
hyperplasia patients. Asian Pac J Cancer Prev. 13:3863–3868. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Arnold RS, Sun Q, Sun CQ, Richards JC,
O'Hearn S, Osunkoya AO, Wallace DC and Petros JA: An inherited
heteroplasmic mutation in mitochondrial gene COI in a patient with
prostate cancer alters reactive oxygen, reactive nitrogen and
proliferation. Biomed Res Int. 2013:2392572013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Arnold RS, Fedewa SA, Goodman M, Osunkoya
AO, Kissick HT, Morrissey C, True LD and Petros JA: Bone metastasis
in prostate cancer: Recurring mitochondrial DNA mutation reveals
selective pressure exerted by the bone microenvironment. Bone.
78:81–86. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Dong YL, Luan ZM, Xue ZY and Li YJ:
Complete mitochondrial genome sequence and mutations of the
prostate cancer model inbred Sprague-Dawley strain. Mitochondrial
DNA A DNA Mapp Seq Anal. 27:2266–2267. 2016.PubMed/NCBI
|
|
53
|
Milosevic M, Warde P, Ménard C, Chung P,
Toi A, Ishkanian A, McLean M, Pintilie M, Sykes J, Gospodarowicz M,
et al: Tumor hypoxia predicts biochemical failure following
radiotherapy for clinically localized prostate cancer. Clin Cancer
Res. 18:2108–2114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Solaini G, Baracca A, Lenaz G and Sgarbi
G: Hypoxia and mitochondrial oxidative metabolism. Biochim Biophys
Acta. 1797:1171–1177. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Feeley KP, Westbrook DG, Bray AW and
Ballinger SW: An ex-vivo model for evaluating bioenergetics in
aortic rings. Redox Biol. 2:1003–1007. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Schuh RA, Clerc P, Hwang H, Mehrabian Z,
Bittman K, Chen H and Polster BM: Adaptation of microplate-based
respirometry for hippocampal slices and analysis of respiratory
capacity. J Neurosci Res. 89:1979–1988. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Perry CG, Kane DA, Lanza IR and Neufer PD:
Methods for assessing mitochondrial function in diabetes. Diabetes.
62:1041–1053. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
de Graaf IA, Olinga P, de Jager MH, Merema
MT, de Kanter R, van de Kerkhof EG and Groothuis GM: Preparation
and incubation of precision-cut liver and intestinal slices for
application in drug metabolism and toxicity studies. Nat Protoc.
5:1540–1551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Martin C, Uhlig S and Ullrich V:
Videomicroscopy of methacholine-induced contraction of individual
airways in precision-cut lung slices. Eur Respir J. 9:2479–2487.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Poosti F, Pham BT, Oosterhuis D, Poelstra
K, van Goor H, Olinga P and Hillebrands JL: Precision-cut kidney
slices (PCKS) to study development of renal fibrosis and efficacy
of drug targeting ex vivo. Dis Model Mech. 8:1227–1236. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lanza IR and Nair KS: Mitochondrial
metabolic function assessed in vivo and in vitro. Curr Opin Clin
Nutr Metab Care. 13:511–517. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Marcinek DJ: Mitochondrial dysfunction
measured in vivo. Acta Physiol Scand. 182:343–352. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Amara CE, Marcinek DJ, Shankland EG,
Schenkman KA, Arakaki LS and Conley KE: Mitochondrial function in
vivo: Spectroscopy provides window on cellular energetics. Methods.
46:312–318. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Campbell MD and Marcinek DJ: Evaluation of
in vivo mitochondrial bioenergetics in skeletal muscle using NMR
and optical methods. Biochim Biophys Acta. 1862:716–724. 2016.
View Article : Google Scholar : PubMed/NCBI
|
